Study of sepsis groups to guide future care
Part of Infections clinical trials.
This study looks at different types (“endotypes”) of sepsis in adults to better understand what’s happening in the body and how patients may respond. You might be asked to provide information and samples as the study tries to sort sepsis into meaningful subgroups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be male or female
- If you have possible sepsis, you must be clinically suspected of having sepsis (doctors are concerned about a serious infection)
- You should be able to participate even if your thinking is not fully clear, and consent can be from you or your surrogate as allowed
- You must not have a blood cancer (hematologic malignancy)
- You must not be pregnant, incarcerated, or unable to speak/read English unless translation is available
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how different genetic types of sepsis affect treatment. It aims to find better therapies for your specific sepsis subtype.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This study looks at how the immune system works in people who are critically ill with sepsis. By understanding these changes, doctors hope to find better ways to treat this serious condition.
This trial looks at how certain genetic elements may affect the immune system in older adults with sepsis. It aims to understand why older patients may respond differently to severe infections.
This study looks at how severe infections (like sepsis) affect the body's immune system over time. It may help researchers find better ways to help patients recover.
This study looks at how certain natural molecules in your blood might affect recovery from severe infections or sepsis. By understanding these molecules, doctors hope to better predict outcomes and personalize treatment for patients in the ICU.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.